Pan Mersey Area Prescribing Committee Formulary

	Pan Mersey Area Prescribing Committee

Search

Formulary Chapter 3: Respiratory system - Full Section
Notes: Review date: September 2018 Non-formulary drugs - any drug or formulation not listed in the formulary is deemed to be non-formulary. Paediatrics - all drugs are deemed to have the same RAG status as they have for adults unless stated otherwise.
Useful Links
NHSE Drug, NHS England Specialised Commissioning: Key documents
NHSE Drug, NHS England Specialised Commissioning: National programmes of care and clinical reference groups
Asthma (children under 5) - inhaler devices (TA10) National Institute for Health and Clinical Excellence Technology Appraisal
Asthma (older children) - inhaler devices (TA38) National Institute for Health and Clinical Excellence Technology Appraisal
High Dose Inhaled Corticosteroids - when to issue a steroid card or ICS card Pan Mersey APC Safety Guidance
NICE CG101 Chronic obstructive pulmonary disease
NICE NG78: Cystic fibrosis: diagnosis and management
NICE NG80: Asthma: diagnosis, monitoring and chronic asthma management
NICE NG9, Bronchiolitis in children: diagnosis and management
NICE TA131 Inhaled corticosteroids for the treatment of chronic asthma in children under the age of 12 years
NICE TA138 Inhaled corticosteroids for the treatment of chronic asthma in adults and in children aged 12 years and over
PAN MERSEY AREA PRESCRIBING COMMITTEE SAFETY STATEMENT, Inhaler comparison and identification guide
Pan Mersey Asthma Management Guidelines for Adults
Pan Mersey Asthma treatment guideline for GP’s and practice nurses - Children 5 years old and over
Pan Mersey Asthma treatment guideline for GP’s and practice nurses - children under 5 years
Pan Mersey COPD Guidelines for Inhaled Therapy
Scottish Intercollegiate Guidelines Network; ‘British guideline on the management of asthma’

03.01	Bronchodilators
	Croup
03.01.01	Adrenoceptor agonists
03.01.01.01	Selective Beta₂ agonists
	Short-acting beta₂ agonists
	Long-acting beta₂ agonists
03.01.01.02	Other adrenoceptor agonists
03.01.02	Antimuscarinic bronchodilators
03.01.03	Theophylline
03.01.04	Compound bronchodilator preparations
03.01.05	Peak flow meters, inhaler devices and nebulisers
	Peak flow meters
	Drug delivery devices
	Nebulisers
	Nebuliser Diluent
03.02	Corticosteroids
03.03	Cromoglicate, related therapy and leukotriene receptor antagonists
03.03.01	Cromoglicate and related therapy
03.03.02	Leukotriene receptor antagonists
03.03.03	Phosphodiesterase type-4 inhibitors
03.04	Antihistamines, hyposensitisation, and allergic emergencies
03.04.01	Antihistamines
	Non-sedating antihistamines
	Sedating antihistamines
03.04.02	Allergen Immunotherapy
	Mepolizumab & Omalizumab
03.04.03	Allergic emergencies
	Anaphylaxis
	Angioedema
03.05	Respiratory stimulants and pulmonary surfactants
03.05.01	Respiratory stimulants
03.05.02	Pulmonary surfactants
03.06	Oxygen
	Long-term oxygen therapy
	Short burst oxygen therpary
	Ambulatory oxygen therapy
	Oxygen therapy equipment
	Arrangements for supplying oxygen
03.07	Mucolytics
03.08	Aromatic inhalations
03.09	Cough preparations
03.09.01	Cough suppressants
03.09.02	Expectorant and demulcent cough preparations
03.10	Systemic nasal decongestants
03.11	Antifibrotics